https://rxmonthly.com/1/hello-world/2019-04-26T16:04:25+00:00https://rxmonthly.com/685/is-rihanna-shooting-a-movie-with-donald-glover/2019-04-26T15:51:08+00:00https://rxmonthly.com/686/chimis-could-this-be-the-best-steak-in-london/2019-04-26T15:43:40+00:00https://rxmonthly.com/687/apparently-this-is-the-best-time-to-apply-for-a-new-job/2019-04-26T15:31:27+00:00https://rxmonthly.com/688/sia-and-scott-walker-to-score-new-natalie-portman-film/2019-04-26T16:01:09+00:00https://rxmonthly.com/689/conversation-with-dominik-mueller/2019-04-26T15:52:34+00:00https://rxmonthly.com/690/forbes-highest-earning-actress-wasnt-even-in-the-top-ten-last-year/2019-04-26T16:07:08+00:00https://rxmonthly.com/691/a-handy-guide-to-louis-therouxs-favourite-documentaries/2019-04-26T16:09:14+00:00https://rxmonthly.com/692/how-to-plan-a-weekend-getaway-to-cleveland/2019-04-26T16:14:36+00:00https://rxmonthly.com/693/10-patriotic-looks-you-can-wear-any-day/2019-04-26T15:56:57+00:00https://rxmonthly.com/694/this-is-what-to-expect-when-you-try-a-vegan-keto-diet/2019-04-26T16:18:35+00:00https://rxmonthly.com/695/john-carpenter-announces-new-halloween-soundtrack/2019-04-26T03:29:33+00:00https://rxmonthly.com/696/the-outlander-cast-had-the-most-hilarious-response-to-their-celebrity-fan/2019-04-26T16:13:03+00:00https://rxmonthly.com/697/yona-the-shoe-fanatic-new-yorker/2019-04-26T15:54:37+00:00https://rxmonthly.com/698/is-there-more-to-life-than-living-in-a-big-city/2019-04-26T15:48:06+00:00https://rxmonthly.com/699/aldi-has-released-their-own-take-on-aperol/2019-04-26T15:46:24+00:00https://rxmonthly.com/700/the-royal-family-has-been-hiding-this-documentary-for-50-years/2019-04-26T15:40:40+00:00https://rxmonthly.com/701/thailand-off-the-beaten-path-with-global-basecamps/2019-04-26T15:08:32+00:00https://rxmonthly.com/702/splash-house-festival-fashion-snaps/2019-04-26T15:15:02+00:00https://rxmonthly.com/703/10-reasons-to-get-into-skateboarding/2019-04-26T15:21:39+00:00https://rxmonthly.com/704/the-best-places-to-go-for-afternoon-tea-in-london/2019-04-26T14:52:15+00:00https://rxmonthly.com/705/welcome-to-dalilas-world-the-osa-peninsula/2019-04-26T15:27:28+00:00https://rxmonthly.com/706/heres-how-cher-responds-to-hollywood-director-calling-her-too-old/2019-04-26T15:38:33+00:00https://rxmonthly.com/707/5-upcoming-eyewear-trends-this-fall/2019-04-26T14:52:46+00:00https://rxmonthly.com/708/this-is-how-to-make-your-avocados-last-longer/2019-04-26T14:51:20+00:00https://rxmonthly.com/709/fast-and-furious-in-the-fall-in-tokyo/2019-04-26T14:51:44+00:00https://rxmonthly.com/710/why-you-need-to-know-the-art-of-celebration/2019-04-26T14:47:30+00:00https://rxmonthly.com/711/tom-cruise-reportedly-in-line-to-play-green-lantern/2019-04-26T14:55:54+00:00https://rxmonthly.com/712/the-best-rooftop-bars-to-cool-off-with-a-drink/2019-04-26T14:59:57+00:00https://rxmonthly.com/713/how-you-can-spend-a-night-at-the-zoo/2019-04-26T15:03:25+00:00https://rxmonthly.com/714/where-to-stay-in-mauritius-for-the-ultimate-escape/2019-04-26T14:50:11+00:00https://rxmonthly.com/891/3-takeaways-from-cancers-biggest-conference/2019-06-06T17:52:13+00:00https://rxmonthly.com/893/from-bio-meeting-merck-ceo-backs-capitalism-rebuts-industrys-critics/2019-06-06T18:17:59+00:00https://rxmonthly.com/896/opioid-maker-insys-to-pay-225m-to-settle-fraud-charges/2019-06-06T18:24:10+00:00https://rxmonthly.com/901/biotechs-dive-deeper-into-targeted-cancer-research-despite-costs/2019-06-06T18:43:15+00:00https://rxmonthly.com/904/rd-leaders-worry-pharma-reputation-risks-losing-talent/2019-06-06T18:51:03+00:00https://rxmonthly.com/907/fdas-woodcock-defends-accelerated-approvals-and-talks-of-culture-shift-in-clinical-trials-2/2019-06-30T00:09:18+00:00https://rxmonthly.com/909/fdas-woodcock-defends-accelerated-approvals-and-talks-of-culture-shift-in-clinical-trials/2019-06-06T19:06:21+00:00https://rxmonthly.com/911/macrogenics-dives-as-breast-cancer-drug-shows-small-improvement/2019-06-06T19:04:30+00:00https://rxmonthly.com/934/pfizer-muscular-dystrophy-gene-therapy-stumbles-on-safety/2019-06-30T00:10:53+00:00https://rxmonthly.com/938/astrazeneca-gets-immuno-oncology-win-in-a-disease-that-merck-doesnt-rule/2019-06-30T00:11:26+00:00https://rxmonthly.com/941/bluebird-sets-1-8m-price-tag-for-blood-disease-gene-therapy/2019-08-17T20:50:00+00:00https://rxmonthly.com/944/ftc-demands-could-mean-months-long-delay-for-roche-spark-deal/2019-06-30T00:12:35+00:00https://rxmonthly.com/947/the-gene-therapy-era-has-arrived-so-have-the-challenges/2019-06-30T00:13:09+00:00https://rxmonthly.com/952/early-cancer-drug-data-give-amgen-hope-it-has-cracked-kras-code/2019-06-30T00:31:57+00:00https://rxmonthly.com/986/abbvie-deal-for-allergan-not-about-the-taxes-thanks-to-2017-law/2019-07-01T16:46:22+00:00https://rxmonthly.com/989/amgen-bone-drug-application-knocked-back-in-europe/2019-07-01T16:48:18+00:00https://rxmonthly.com/992/once-bodies-for-hire-cros-are-finding-a-new-role-as-data-specialists/2019-07-01T16:52:25+00:00https://rxmonthly.com/999/bayer-backs-cell-therapy-startup-with-215m-in-funding/2019-07-01T16:56:10+00:00https://rxmonthly.com/1002/former-fda-head-gottlieb-joins-pfizer-board/2019-07-01T16:56:22+00:00https://rxmonthly.com/1007/zolgensma-set-a-new-drug-pricing-bar-insurers-show-some-signs-of-pushback/2019-07-05T23:16:29+00:00https://rxmonthly.com/1012/gilead-firms-up-path-to-market-for-key-arthritis-drug/2019-07-05T23:19:38+00:00https://rxmonthly.com/1015/amicus-widens-upenn-gene-therapy-collaboration/2019-07-05T23:21:19+00:00https://rxmonthly.com/1018/array-gets-a-win-in-colorectal-cancer/2019-07-05T23:24:52+00:00https://rxmonthly.com/1023/no-news-is-bad-news-for-tocagen/2019-07-05T23:30:25+00:00https://rxmonthly.com/1029/intra-cellulars-depression-drug-goes-1-for-2-in-phase-3-studies/2019-07-08T17:29:36+00:00https://rxmonthly.com/1032/sangamo-backs-up-early-success-for-hemophilia-gene-therapy/2019-07-08T17:30:45+00:00https://rxmonthly.com/1035/roche-acknowledges-the-obvious-extends-spark-buyout-deadline/2019-07-08T17:37:34+00:00https://rxmonthly.com/1039/biomarin-confirms-timeline-for-hemophilia-gene-therapy-putting-pressure-on-rivals/2019-07-08T17:35:00+00:00https://rxmonthly.com/1044/rival-accuses-kaleo-of-cybersquatting-in-elaborate-scheme/2019-07-08T17:36:30+00:00https://rxmonthly.com/1088/celgene-wins-approval-for-drug-key-to-bristol-buyout/2019-08-17T05:17:55+00:00https://rxmonthly.com/1091/novo-faces-shareholder-suit-over-insulin-sales-disclosures/2019-08-17T05:17:32+00:00https://rxmonthly.com/1094/roche-cancer-drug-the-3rd-approved-for-pan-tumor-use/2019-08-17T05:16:20+00:00https://rxmonthly.com/1097/cms-chief-declines-to-provide-details-on-trump-healthcare-plan/2019-08-17T05:15:11+00:00https://rxmonthly.com/1103/nonprofit-under-pressure-to-make-new-tb-drug-affordable/2019-08-20T20:51:28+00:00